(Q44613172)

4 December 2017

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial (English)

1 reference

4 December 2017

1 reference

5

1 reference

4 December 2017

Matthijs Janssen

2

0 references

author name string

Hein J E M Janssens

series ordinal

1

1 reference

4 December 2017

Eloy H van de Lisdonk

series ordinal

3

1 reference

4 December 2017

Piet L C M van Riel

series ordinal

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

4 December 2017

1 reference

4 December 2017

371

1 reference

4 December 2017

9627

1 reference

4 December 2017

1854-1860

1 reference

4 December 2017

Clinical practice. Gout

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

The severe gout of Holy Roman Emperor Charles V.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Alcohol intake and risk of incident gout in men: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Gout, not induced by diuretics? A case-control study from primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Gout: on the brink of novel therapeutic options for an ancient disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

The economic burden of gout on an employed population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Does colchicine work? The results of the first controlled study in acute gout.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Colchicine for acute gout

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Diagnosis and management of gout

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Effectiveness of interventions for the treatment of acute and prevention of recurrent gout--a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Gout in the elderly. Clinical presentation and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Gout, just a nasty event or a cardiovascular signal? A study from primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Gout and the risk of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Early emergency department treatment of acute asthma with systemic corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Systemic corticosteroids for acute gout

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Clinical significance of reported changes in pain severity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Do quantitative changes in pain intensity correlate with pain relief and satisfaction?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Patient-perceived satisfactory improvement (PPSI): Interpreting meaningful change in pain from the patient’s perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

Systemic steroid therapy for acute gout: a clinical trial and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960799-0

7 January 2021

10.1016/S0140-6736(08)60799-0

Identifiers

DOI

1 reference

4 December 2017

1 reference